1,1''-(Dodecane-1,12-diyl)diquinolinium bromide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1,1''-(Dodecane-1,12-diyl)diquinolinium bromide
• 英文别名: 1-(12-quinolin-1-ium-1-yldodecyl)quinolin-1-ium
• 化学式: C30H38N2+2
• 分子量: 426.6
• InChiKey: KQWKYDIWXCLYSS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9
• 重原子数：
  32
• 可旋转键数：
  13
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  7.8
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
  申请人：Crooks A. Peter

  公开号：US20050261334A1

  公开（公告）日：2005-11-24

  N-n-Alkylation of nicotine converts nicotine from an agonist into an antagonist specifically for neuronal nicotinic acetylcholine receptor subtypes mediating nicotine-evoked dopamine release. Conformationally restricted analogs exhibit both high affinity and selectivity at this site, and are able to access the brain due to their ability to act as substrates for the blood-brain barrier choline transporter.

  尼古丁的N-n-烷基化将尼古丁从激动剂转化为拮抗剂，特别是对于介导尼古丁诱导的多巴胺释放的神经尼古丁乙酰胆碱受体亚型。构象限制类似物在该位点表现出高亲和力和选择性，并能够进入大脑，因为它们能够作为血脑屏障胆碱转运体的底物。
• BIS-PYRINDINO CONTAINING COMPOUNDS FOR THE USE IN THE TREATMENT OF CNS PATHOLOGIES
  申请人：CROOKS Peter A.

  公开号：US20100152237A1

  公开（公告）日：2010-06-17

  N-n-Alkylation of nicotine converts nicotine from an agonist into an antagonist specifically for neuronal nicotinic acetylcholine receptor subtypes mediating nicotine-evoked dopamine release. Conformationally restricted analogs exhibit both high affinity and selectivity at this site, and are able to access the brain due to their ability to act as substrates for the blood-brain barrier choline transporter.

  尼古丁的N-烷基化将尼古丁从激动剂转变为拮抗剂，特别针对介导尼古丁引起多巴胺释放的神经尼古丁乙酰胆碱受体亚型。构象限制性类似物在该位点表现出高亲和力和选择性，并能够进入大脑，因为它们能够作为血脑屏障胆碱转运体的底物。
• US8546415B2
  申请人：——

  公开号：US8546415B2

  公开（公告）日：2013-10-01